Each of the National Consumer Credit Reporting bureaus have a unique credit report format, but in essence they provide you with the same information. When you receive your
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
href="http://www.poorcreditgenie.com/getfree.html">free Equifax credit report use the following guidelines to read your report:
Personal Information
This section will detail you
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
personal information: Name, Social Security Number (SSN), date of birth, any former names, death notice information, current address, previous addresses, any other identification numbers th
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
at you may have, current employer and previous employers.
You will also find information about any fraud alerts that you may have against your credit report.
Account Information Summary
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
You’ll find a list of all your accounts here. Additional information will include account type, account number, date account was opened, account balance, any past due amount, account s
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
atus and credit limit.
Inquiries
Any inquiries against your credit file will be listed in this section. This section is divided into two subcategories: (a) Inquiries that display to
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
companies and may impact your credit score. (b) Inquiries that do not display to companies and do not impact your credit score.
“Inquiries that display to companies and may impact your cre
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
dit score”
These are inquiries by potential creditors who are assessing whether to extend you a line of credit or not. Your credit score will be minimally affected and therefore these inqui
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ies should not be of major concern, unless there are some red flags. The name of the company that requested the information and the date they requested it will be listed.
“Inquiries that do
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
not display to companies and do not impact your credit score”
Unlike the previous inquiries – these do not “hurt” your credit score. They include inquiries for pre-approved credit lines, i
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
nsurance, or account reviews by existing creditors. The name of the company that requested the information, the date they requested it and the type of inquiry will be listed.
Collections
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Any accounts that have gone to collections will be listed here along with the name of the creditor, date reported, creditor type, your account number, original amount, dates of delinqu
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ncy, outstanding balance and status information.
Public Records
Bankruptcies, liens or judgments information from federal, state or county court records will be listed here. Each pu
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
blic record will indicate the type of record, case number, amount in default and any relevant information associated with that particular case.
You may also find the following credit report
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
terms helpful:
CURR ACCT – Account is current in payments and in good standing.
CUR WAS 30-2 – Account is current was 30 days late twice.
PAID – Account has been paid off y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
nd has a $0 balance and is inactive.
CHARGEOFF – Unpaid balance on account was reported as a loss by creditor and the creditor is no longer seeking reimbursement.
COLLECT – Accou.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
nt is severely delinquent and assigned to collections.
FORECLOS – Property was foreclosed.
BKLIQREQ – Debt was forgiven due to Chapter 7, 11 or 13.
DELINQ 60 – Account is 6elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products